Original Research

Comparable efficacy and less toxicity of pegylated liposomal doxorubicin versus epirubicin for neoadjuvant chemotherapy of breast cancer: a case-control study

Dong M, Luo L, Ying X, Lu X, Shen J, Jiang Z, Wang L

OncoTargets and Therapy 2018, 11:4247-4252

Published Date: 23 July 2018